中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
The Interim Efficacy of Epigenetic Priming Regimen with Azacytidine and Chidamide in Patients with Relapsed or Refractory Peripheral T Cell Lymphoma

文献类型:期刊论文

作者Ding, Kaiyang1; Shi, Xiao2; Yang, Haiyan4; Cao, Lei2; Zhao, Xiaoli2; Liu, Hailing2; Wu, Wei2; Zhang, Xiaoyan2; Wang, Li2; Xu, Wei2
刊名BLOOD
出版日期2021-11-23
卷号138
ISSN号0006-4971
DOI10.1182/blood-2021-150523
WOS研究方向Hematology
语种英语
出版者AMER SOC HEMATOLOGY
WOS记录号WOS:000736413901190
源URL[http://ir.hfcas.ac.cn:8080/handle/334002/131852]  
专题中国科学院合肥物质科学研究院
作者单位1.USTC, Affiliated Hosp 1, Dept Hematol, Anhui Prov Hosp, Hefei, Peoples R China
2.Nanjing Med Univ, Jiangsu Prov Hosp, Dept Hematol, Affiliated Hosp 1, Nanjing, Peoples R China
3.Natl Clin Res Ctr Hematol Dis, Suzhou, Peoples R China
4.Univ Chinese Acad Sci, Canc Hosp, Zhejiang Canc Hosp, Dept Med Oncol, Hangzhou, Peoples R China
推荐引用方式
GB/T 7714
Ding, Kaiyang,Shi, Xiao,Yang, Haiyan,et al. The Interim Efficacy of Epigenetic Priming Regimen with Azacytidine and Chidamide in Patients with Relapsed or Refractory Peripheral T Cell Lymphoma[J]. BLOOD,2021,138.
APA Ding, Kaiyang.,Shi, Xiao.,Yang, Haiyan.,Cao, Lei.,Zhao, Xiaoli.,...&Fan, Lei.(2021).The Interim Efficacy of Epigenetic Priming Regimen with Azacytidine and Chidamide in Patients with Relapsed or Refractory Peripheral T Cell Lymphoma.BLOOD,138.
MLA Ding, Kaiyang,et al."The Interim Efficacy of Epigenetic Priming Regimen with Azacytidine and Chidamide in Patients with Relapsed or Refractory Peripheral T Cell Lymphoma".BLOOD 138(2021).

入库方式: OAI收割

来源:合肥物质科学研究院

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。